Immatics Biotechnologies Gmbh
Patents = 725
Trademarks = 25
Forward Citations = 5,483
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
127 inventors (with patents filed for the assignee):
IMMATICS Biotechnologies GmbH is a clinical-stage biopharmaceutical company focused on the development of innovative cancer immunotherapies. With its headquarters in Germany, IMMATICS leverages its proprietary XmAb cell therapy platform to discover, develop, and manufacture cutting-edge immunotherapies with the potential to transform cancer treatment. The company's vision is to harness the power of the immune system to significantly improve outcomes for cancer patients.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com